Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

12.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.0K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

508
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
508
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

475
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
475
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

633
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
633
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

4.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
4.8K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.6K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editor's Note.

Biochemical pharmacology·2022
Same author

Note to Readers.

Biochemical pharmacology·2019
Same author

Today's research, tomorrow's health: focus on pharmacogenomics.

Personalized medicine·2018
Same author

A tribute to Norman G Bowery.

Neuropharmacology·2018
Same author

Diamond Jubilee Special Issue: Celebrating 60 years of Excellence.

Biochemical pharmacology·2018
Same author

Editorial.

Biochemical pharmacology·2018

Related Experiment Video

Updated: Feb 14, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

14.3K

Receptor Binding Assays and Drug Discovery.

David B Bylund1, S J Enna2

  • 1University of Nebraska Medical Center, Omaha, NE, United States.

Advances in Pharmacology (San Diego, Calif.)
|February 8, 2018
PubMed
Summary
This summary is machine-generated.

Solomon Snyder

Keywords:
Drug discoveryFunctional assaysHistory of scienceLigand binding assaysNeurotransmitter receptorPhenotypic assaysRadioligandReceptor binding

More Related Videos

In Vitro Transcription Assays and Their Application in Drug Discovery
09:28

In Vitro Transcription Assays and Their Application in Drug Discovery

Published on: September 20, 2016

15.7K
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.8K

Related Experiment Videos

Last Updated: Feb 14, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

14.3K
In Vitro Transcription Assays and Their Application in Drug Discovery
09:28

In Vitro Transcription Assays and Their Application in Drug Discovery

Published on: September 20, 2016

15.7K
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.8K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Drug Discovery

Background:

  • Solomon Snyder's foundational work in neuroscience.
  • Development of neurotransmitter receptor radioligand binding assays.

Purpose of the Study:

  • To highlight the impact of Snyder's receptor binding assays on neuroscience and drug discovery.
  • To explain the evolution of drug discovery from empirical to mechanistic approaches.

Main Methods:

  • Radioligand binding assays for receptor characterization.
  • Integration of binding assays with functional, phenotypic assays in drug discovery.

Main Results:

  • Receptor binding assays provided a powerful tool for identifying and characterizing neurotransmitter receptors.
  • This technique advanced the understanding of neurological and psychiatric disorders.
  • Ligand binding assays, when combined with functional assays, proved crucial for novel drug discovery.

Conclusions:

  • Snyder's work significantly impacted neuroscience research and drug development.
  • The integration of binding assays shifted drug discovery towards a hypothesis-driven methodology.
  • His contributions transformed the search for therapeutics for various medical conditions.